sb 203580 has been researched along with 5-iodoindirubin-3'-monoxime in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (5-iodoindirubin-3'-monoxime) | Trials (5-iodoindirubin-3'-monoxime) | Recent Studies (post-2010) (5-iodoindirubin-3'-monoxime) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 8 | 0 | 0 |
| Protein | Taxonomy | sb 203580 (IC50) | 5-iodoindirubin-3'-monoxime (IC50) |
|---|---|---|---|
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.025 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.015 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.025 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.418 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.009 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.02 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.02 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.025 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for sb 203580 and 5-iodoindirubin-3'-monoxime
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |